- Home
- THRD vs ATNI Comparison
THRD vs ATNI Comparison
Compare THRD & ATNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THRD
- ATNI
- Stock Information
- Founded
- THRD 2019
- ATNI 1987
- Country
- THRD United States
- ATNI United States
- Employees
- THRD N/A
- ATNI N/A
- Industry
- THRD Biotechnology: Pharmaceutical Preparations
- ATNI Telecommunications Equipment
- Sector
- THRD Health Care
- ATNI Telecommunications
- Exchange
- THRD Nasdaq
- ATNI Nasdaq
- Market Cap
- THRD 238.7M
- ATNI 240.0M
- IPO Year
- THRD 2022
- ATNI 1991
- Fundamental
- Price
- THRD $5.42
- ATNI $16.14
- Analyst Decision
- THRD Hold
- ATNI Strong Buy
- Analyst Count
- THRD 3
- ATNI 1
- Target Price
- THRD $5.00
- ATNI $30.00
- AVG Volume (30 Days)
- THRD 251.2K
- ATNI 45.1K
- Earning Date
- THRD 08-07-2025
- ATNI 07-23-2025
- Dividend Yield
- THRD N/A
- ATNI 5.95%
- EPS Growth
- THRD N/A
- ATNI N/A
- EPS
- THRD N/A
- ATNI N/A
- Revenue
- THRD N/A
- ATNI $721,575,000.00
- Revenue This Year
- THRD N/A
- ATNI $2.03
- Revenue Next Year
- THRD N/A
- ATNI $1.59
- P/E Ratio
- THRD N/A
- ATNI N/A
- Revenue Growth
- THRD N/A
- ATNI N/A
- 52 Week Low
- THRD $3.18
- ATNI $13.76
- 52 Week High
- THRD $16.02
- ATNI $33.72
- Technical
- Relative Strength Index (RSI)
- THRD 68.70
- ATNI 54.98
- Support Level
- THRD $5.41
- ATNI $15.14
- Resistance Level
- THRD $5.52
- ATNI $16.66
- Average True Range (ATR)
- THRD 0.05
- ATNI 0.51
- MACD
- THRD -0.01
- ATNI 0.12
- Stochastic Oscillator
- THRD 64.29
- ATNI 65.79
About THRD Third Harmonic Bio Inc.
Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.
About ATNI ATN International Inc.
ATN International Inc is a telecommunications and utilities company. The company provides digital infrastructure and communications services with a focus on rural and remote markets in the United States, and internationally, including Bermuda and the Caribbean region. Its operating segments comprise U.S. Telecom and International Telecom. The company earns revenue from its International telecommunication segment.